Lee Daniel Arnold,Hans Maag,William W. Turner, Jr.
申请号：
US15566633
公开号：
US20180099952A1
申请日:
2016.04.15
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Novel assembly effector compounds having a therapeutic effect against hepatitis B viral (HBV) infection are disclosed. Assembly effector molecules described herein can lead to defective viral assembly and also may affect other viral activities associated with chronic HBV infection. Also disclosed is a process to synthesize disclosed compounds, method of treatment of HBV by administration of disclosed compounds, and use of these compounds in the manufacture of medicaments against HBV.
